Latest study demonstrates a machine learning model improved Bio-RFID™ sensor’s accuracy for predicting blood glucose, using the Dexcom G6® as reference device “A MARD of 12.9% at this stage in our ...

Publication reports statistically significant improvement in sleep quality following treatment with Nexalin’s 15 mA, 77.5 Hz ...

A new technology has been developed that enables cuffless non-invasive blood pressure monitoring by using ultrasonic to track real-time changes in vascular diameter-without the need for a traditional ...

The startup specializes in "non-invasive" "mind-reading" tech—a kind of neural data collection that, its CEO hopes, will have ...

CorVista Health has announced a research collaboration with Mayo Clinic to evaluate how next-generation, non-invasive diagnostics may transform the identification and management of pulmonary ...

JACKSONVILLE, Fla. — A local hospital is using new technology to remove liver cancer without invasive surgery. It’s a word that no one ever wants to hear. “He found the cancer,” Paul Montgomery said.

VARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced ...

NexGen Health, a physician-led regenerative and aesthetic medicine clinic based in Silicon Valley, today announced the launch of XERF, an advanced non-invasive treatment designed to support skin ...

TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today the treatment of the initial patient for its first-in-human clinical trial evaluating the company's groundbreaking ...

Detailed price information for Nexalin Technology Inc (NXL-Q) from The Globe and Mail including charting and trades.

The nucleus accumbens is a tiny element of the human brain triggered when we experience something enjoyable, and used to help us learn behaviours that lead to rewards. A new study has shown for the ...